Filing Details
- Accession Number:
- 0001127602-18-016117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-03 08:44:28
- Reporting Period:
- 2018-05-01
- Accepted Time:
- 2018-05-03 08:44:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1650274 | Ross David Smith | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-01 | 945 | $51.45 | 13,723 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $103.67 | 13,623 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $103.73 | 13,523 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $103.84 | 13,423 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $104.11 | 13,323 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $104.29 | 13,223 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $104.33 | 13,123 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $104.44 | 13,023 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 100 | $104.53 | 12,923 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 5 | $104.54 | 12,918 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-01 | 140 | $104.87 | 12,778 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-05-01 | 945 | $0.00 | 945 | $51.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-05-01 | 2021-05-01 | No | 4 | M | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
